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emic. The last of these is called Swine ﬂue (inﬂuenza A
1N1), which since its inception has caused great alarm,
igh morbidity and mortality especially in pregnant women.
his is a sample of the features of the disease in Dominican
epublic.
Dominican Republic is a tropical country located in
he Caribbean that receive substantial annual number of
ourists, which makes inﬂuenza outbreaks throughout the
ear: both seasonal peaks in the northern and southern
emisphere.
Methods: The Epidemiology National Program starts a
urveillance since the epidemic arise at level 5, at epidemi-
logical week 16.
Diagnosis conﬁrmation was made with rt- PCR for A H1N1
o all symptomatic respiratory cases.
Results: Until the 40th epidemiology week, we have
,664 suspicious cases, 997 (37%) hospitalized, 441 con-
rmed cases, from this 191 (45%) hospitalized, and 22 (5%)
eath, 76 (17%) cases were pregnant women with 16% mor-
ality.
Clinical manifestations were: fever (94%), cough (89%),
asal congestion (76%), headache (71%), muscle pain (67%),
ore throat (60%), dyspnoea (45%), nausea (25%), rales (21%),
omiting (18%) and diarrhoea (11%).
Pregnancy was one of the more important risk factor
ssociated with mortality.
Necropsy ﬁndings where: edema, hemorrhage and necro-
is in lung tissues, frequently associate with intravascular
hrombosis.
High mortality was cause due a delay in search of medi-
al attention and no suspected diagnosis from health cares
ersonel.
Conclusion: It must be increased the Primary Care Ser-
ices to obtain an early diagnosis of the disease, and began
he antiviral treatment in high risk populations, when this
athology is suspected, mostly in pregnant women.
oi:10.1016/j.ijid.2010.02.1711
8.042
rolonged prophylaxis for A H1N1 Inﬂuenza pandemic in
ncohematologic patients - Adherence, security and efﬁ-
iency
.J. Ramirez Borga1,∗, A.S. Firpo2, L. Lopez3, J.J. Napal3,
.V. Prates3, S. Yantorno3, A. Enrico3, J. Milone3
Hospital Italiano de La Plata, La Plata, Buenos Aires,
rgentina
Hospital Italiano La Plata, La Plata, Buenos Aires,
rgentina
Hospital Italiano La Plata, La Plata, Argentina
Background: Since 1 May to 31 October 2009, 1,241,612
ases of a kind of Inﬂuenza disease were notiﬁed in Argen-
ine. 24,504 virologic samples were processed, conﬁrming
hat 10,248 were cases of AH1N1 Inﬂuenza, there were
2,471 cases that required hospitalization and 600 conﬁrmed
eaths.
Oncohematologic patients were in the high risk group to
his infection. As a preventive strategy a prolonged prophy-
axis with oseltamivir was administered during 30 days.
(
o
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Our objetive was value the adherence, security and efﬁ-
iency of the prolonged prophylaxis against AH1N1 Inﬂuenza
ith oseltamivir in an oncohematologic patients cohort.
Methods: From July to September 2009, a prospective
tudy was performed from a cohort of 45 oncohematologic
atients above 19 years old, that received a 75mg daily dose
f oseltamivir during 30 days. Then, by an anonymous survey,
ge was consulted, as well as sex, oncohematologic pathol-
gy, treatment performance, adverse effects that patients
resented, doses that were used, whether and why medica-
ion was interrupted, concomitant medication and whether
he patient had to consult the doctor during that period of
ime.
Results: Nor Inﬂuenza Syndromes were registered in the
ohort, neither Inﬂuenza cases during the administration of
uch prophylaxis. Medium age was 54 years (range 19-87), 22
emales and 23 males. Basal diseases were Lymphomas in 42,
% of the cases; Acute Leukemias in 24%; Multiple Myeloma
n 17, 8%; Hodgkin disease in 11,1% and Myelodysplasia in
,7%.
From 45 patients, 24 (53, 3%) presented adverse effects,
0% with digestive symptoms, 18% neurologic and 15%
atigue.
In 34 patients (75, 5%) a 100% adherence was achieved.
rom those patients that did not ﬁnish the treatment, 5
aid that it was because they had a digestive intolerance,
did not give their reasons and another one because he/she
egan late.
No serious adverse effects requiring hospitalization were
bjectived.
There were 32 patients that were already receiving other
edication during antiviral prophylaxis, and only 6 patients
ad to consult their doctor during such period of time.
Conclusion: Daily prophylaxis efﬁciency with oseltamivir
as successful in 100% of the cases. The adherence to
seltamivir was partial (75,5%) mainly because of digestive
ntolerance. No serious adverse effects were detected.
oi:10.1016/j.ijid.2010.02.1712
8.043
omologous and heterologous immune responses to
aturally-acquired inﬂuenza virus infection
. Lau ∗, V.J. Fang, K.H. Chan, E. Ma, G.M. Leung, M. Peiris,
.J. Cowling
The University of Hong Kong, Hong Kong, China
Background: Humoral antibody responses, typically mea-
ured by hemagglutination inhibition (HAI) and viral
eutralization, are common measures of immunity to
nﬂuenza virus infection. An antibody titer of greater than
:40 is thought to correlate to around 50% protection to
nfection, while a 4-fold rise in antibody titers between two
imes is evidence of infection during that interval. Infec-
ion from a speciﬁc strain of inﬂuenza can elicit an antibody
esponse against other strains of inﬂuenza, which may cor-
elate with protection.Methods: Subjects presenting with inﬂuenza like illness
ILI) were recruited from general outpatient clinics through-
ut Hong Kong. Those subjects who tested positive for
nﬂuenza by a rapid diagnostic test, and their household
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members, were followed up with home visits to determine
secondary infections in the household. Serum samples taken
at baseline and convalescence were tested for HAI speciﬁc
to pandemic H1N1, seasonal H1N1 and seasonal H3N2. Nasal
and throat swabs (NTS) were collected from each individual
and tested by RTPCR to conﬁrm active infections.
Results: There were 18 pandemic H1N1, 5 seasonal H1N1,
and 24 seasonal H3N2 virus positive cases conﬁrmed by
RT-PCR. Among those positive for inﬂuenza virus, 39 were
adults (‘‘16 years) and 8 were children. The proportion of
individuals with a homologous antibody titer of ≥1:40 rose
from 17%, 20% and 4% to 78%, 100% and 38% after infection
with the pandemic H1N1, seasonal H1N1 and seasonal H3N2
viruses respectively. Heterologous responses were strongest
between pandemic H1N1 and seasonal H1N1. In individuals
with RT-PCR conﬁrmed seasonal H1N1 infection, the pro-
portion with an antibody titer ‘‘1:40 for pandemic H1N1
increased from 20% to 40%. In the opposite direction, the
proportion of those conﬁrmed with pandemic H1N1 with an
antibody titer ≥1:40 for seasonal H1N1 increased from 33%
to 44%. Low levels of cross-strain HAI titer rise to ≥1:40 were
detected in other variations.
Conclusion: We identiﬁed low baseline immunity prior
to naturally-acquired infection with seasonal or pandemic
strains of inﬂuenza in the 2009 summer season in Hong Kong.
This suggests that a proportion of those infected with either
seasonal H1N1 or H3N2 viruses could gain protection against
the novel pandemic H1N1 strain and vice-versa.
doi:10.1016/j.ijid.2010.02.1713
28.044
The role of schools as social networks in transmission of
Inﬂuenza A (H1N1 2009): The Mbulu District, Northern
Tanzania, November 2009 experience
E. Mwakapeje1,∗, J. Mghamba1, E. Nyale2, M.A. mohamed1,
V. Makundi3, O. Oleribe1, P. Mmbuji 4
1 Tanzanian Field Epidemiology and Laboratory Training Pro-
gram (TFELTP), Dar Es Salaam, Tanzania, United Republic
of
2 School of Public Health Muhimbili University of Health
and Allied Sciences, DAR ES SALAAM, CA, Tanzania, United
Republic of
3 Ministry of health and social welfare, 22, Tanzania, United
Republic of
4 Tanzanian Ministry of Health and Social Welfare, Dar Es
Salaam, Tanzania, United Republic of
Background: Novel inﬂuenza A H1N1 virus is the latest
emerging viral disease with a pandemic phase 6 status. Since
July 4th when the ﬁrst case was conﬁrmed in Tanzania, there
have been several sporadic cases across several regions. A
cluster of cases were identiﬁed at a school in Mbulu dis-
trict on September 16th 2009, Northern Tanzania. Within
a week, 94 cases were conﬁrmed (72 in the school and 22
within the community). This prompted immediate outbreak
investigation, risk factor analysis and establishment of con-
trol measures. We describe the steps taken to curtail this
health event in Tanzania.
Methods: An unmatched case control study was done. A
case was deﬁned as any person with acute respiratory ill-
a
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ess from Mbulu district with laboratory conﬁrmed inﬂuenza
(H1N1) virus or who is epidemiologically linked to a con-
rmed case. Cases were actively searched and identiﬁed;
pecimens were collected and sent to the National Inﬂuenza
entre in Dar es Salaam for rt-PCR conﬁrmatory testing for
nﬂuenza A (H1N1). Data analysis was done using Epi info
.5.1
Results: The index case was a student of the school and
rom September 16, through October 5, a total of 99 were
onﬁrmed with Inﬂuenza A H1N1. The mean age of cases was
6 years (SD=8.4); 78% of patients were less than 20 years.
wenty two percent were identiﬁed from the community
ollowing a graduation activity at the school on Septem-
er 26, 2009. The most common presenting symptoms were
ever (90%), cough (46%), headache (40%), and Joint pains
30%). Signiﬁcant transmission occurred in the class and dor-
itory where the ﬁrst case was identiﬁed (attack rate =
3.8%)..Being present in a graduation gathering was found to
e a risk factor for developing the disease at the community
evel (OR=1.4, 95%CI= 1.2—6.0).
Conclusion: Following the outbreaks and the subsequent
ommunity spread, Tanzanian FELTP residents and MoHSW
ere co-opted to investigate, control and prevent future
pread. The epidemic was subsequently controlled and
urveillance reinforced. Early identiﬁcation and institution-
lization of control measures are vital tools in shifting
pidemic curves to the left.
oi:10.1016/j.ijid.2010.02.1714
8.045
o-infection between the pandemic inﬂuenza virus A
1N1 and seasonal inﬂuenza A virus in a patient present-
ng severe acute respiratory disease
. Feltrin1, K. Augusto1, V. Isper1, J. Delamain1, B. Kemp2,
.R.R. Freitas2, M. Pacola3, R. Angerami4,∗
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ealth VII,State Department of Health of São Paulo, Camp-
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State University of Campinas, Campinas, SP, Brazil
Background: With the pandemic circulation of the new
nﬂuenza A/H1N1 virus in 2009, became mandatory to imple-
ent the national preparedness plan to improve both health
are and laboratory settings activities. However, it is also
mportant a continuous surveillance is essential to promote
better comprehension of mechanisms of transmission, viral
irulence, and treatment efﬁcacy. The aim of this study is
o describe the clinical, laboratorial, and epidemiological
spects of a fatal case of severe acute respiratory disease
SARD) with simultaneous identiﬁcation of both pandemic
nd seasonal inﬂuenza A virus.
Methods: Retrospective and descriptive study based on
nformation collected in medical records and notiﬁcation ﬁle
bout a patient hospitalized in Campinas, State of São Paulo,
uring the ﬁrst inﬂuenza A/H1N1 epidemic period in Brazil.
Results: A white female patient, 25 years old, with
ntecedent of obesity and diabetes, was admitted in
